Patents by Inventor Tanny Chen Tsao

Tanny Chen Tsao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating autoimmune disease by administering antibodies to interleukin-6
    Patent number: 10370443
    Abstract: The present disclosure provides antibodies that bind to human interleukin-6 (IL6). The antibodies can modulate IL6 signaling and thus used in treatment or prevention of IL6 associated diseases or disorders, particularly inflammatory disorder, rheumatoid arthritis (RA), angiogenesis, and cancer.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: August 6, 2019
    Assignee: Fountain Biopharma Inc.
    Inventors: Tong-Young Lee, Han-Chung Wu, Tanny Chen Tsao, Willie Lin
  • USES OF ANTIBODIES TO INTERLEUKIN-6 IN CANCER TREATMENT
    Publication number: 20170362317
    Abstract: The present disclosure provides antibodies that bind to human interleukin-6 (IL6). The antibodies can modulate IL6 signaling and thus used in treatment or prevention of IL6 associated diseases or disorders, particularly inflammatory disorder, rheumatoid arthritis (RA), angiogenesis, and cancer.
    Type: Application
    Filed: August 25, 2017
    Publication date: December 21, 2017
    Applicant: Fountain Biopharma Inc.
    Inventors: Tong-Young Lee, Han-Chung Wu, Tanny Chen Tsao, Willie Lin
  • Uses of antibodies to interleukin-6 in cancer treatment
    Patent number: 9758580
    Abstract: The present disclosure provides antibodies that bind to human interleukin-6 (IL6). The antibodies can modulate IL6 signaling and thus used in treatment or prevention of IL6 associated diseases or disorders, particularly inflammatory disorder, rheumatoid arthritis (RA), angiogenesis, and cancer.
    Type: Grant
    Filed: December 31, 2015
    Date of Patent: September 12, 2017
    Assignee: Fountain Biopharma Inc.
    Inventors: Tong-Young Lee, Han-Chung Wu, Tanny Chen Tsao, Willie Lin
  • ANTIBODIES TO INTERLEUKIN-6 AND USE THEREOF
    Publication number: 20160185851
    Abstract: The present disclosure provides antibodies that bind to human interleukin-6 (IL6). The antibodies can modulate IL6 signaling and thus used in treatment or prevention of IL6 associated diseases or disorders, particularly inflammatory disorder, rheumatoid arthritis (RA), angiogenesis, and cancer.
    Type: Application
    Filed: December 31, 2015
    Publication date: June 30, 2016
    Applicant: Fountain Biopharma Inc.
    Inventors: Tong-Young Lee, Han-Chung Wu, Tanny Chen Tsao, Willie Lin
  • Antibodies to interleukin-6
    Patent number: 9234035
    Abstract: The present disclosure provides antibodies that bind to human interleukin-6 (IL6). The antibodies can modulate IL6 signaling and thus used in treatment or prevention of IL6 associated diseases or disorders, particularly inflammatory disorder, rheumatoid arthritis (RA), angiogenesis, and cancer.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: January 12, 2016
    Assignee: Fountain Biopharma Inc.
    Inventors: Tong-Young Lee, Han-Chung Wu, Tanny Chen Tsao, Willie Lin
  • ANTIBODIES TO INTERLEUKIN-6 AND USE THEREOF
    Publication number: 20140112935
    Abstract: The present disclosure provides antibodies that bind to human interleukin-6 (IL6). The antibodies can modulate IL6 signaling and thus used in treatment or prevention of IL6 associated diseases or disorders, particularly inflammatory disorder, rheumatoid arthritis (RA), angiogenesis, and cancer.
    Type: Application
    Filed: October 18, 2013
    Publication date: April 24, 2014
    Applicant: Fountain Biopharma Inc.
    Inventors: Willie Lin, Tong-Young Lee, Han-Chung Wu, Tanny Chen Tsao